design, setting, and participants: randomized trial with enrollment at 4 clinical centers (january 2000-june 2001) among 810 adults (mean [sd] age, 50 [8.9] years; 62% women; 34% african american) with above-optimal bp, including stage 1 hypertension (120-159 mm hg systolic and 80-95 mm hg diastolic), and who were not taking antihypertensive medications.